Literature DB >> 9171503

Short-term results of IPS-Empress inlays and onlays.

S Studer1, C Lehner, U Brodbeck, P Schärer.   

Abstract

PURPOSE: A leucite-reinforced, glass-ceramic material was recently introduced for clinical use. In this clinical trial, IPS-Empress inlays and onlays were evaluated using the modified United States Public Health Service (USPHS) criteria.
MATERIALS AND METHODS: The teeth of 36 patients were restored with 105 posterior inlays and 25 onlays, fabricated by an indirect technique. After etching the restorations with hydrofluoric acid, they were silanized and luted using composite cements. The restorations were evaluated visually, clinically with a mirror and probe, and by bitewing radiographs and clinical photographs, using modified USPHS criteria. Restorations having neither charlie nor delta criteria were defined as successful, and their survival rate was calculated according to Kaplan-Meier analysis.
RESULTS: The mean observation period for the 130 restorations was 23.4 +/- 6.1 months. After 2 years, 127 restorations were successful with an estimated survival rate of 97.5%. Three restorations failed because of fractures. The esthetic results were excellent.
CONCLUSIONS: The initial clinical results of this esthetic restorative material are encouraging. However, because of fatigue phenomena for all ceramic materials, a longer observation period is needed to provide a definitive prognosis of the long-term clinical behavior.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9171503     DOI: 10.1111/j.1532-849x.1996.tb00512.x

Source DB:  PubMed          Journal:  J Prosthodont        ISSN: 1059-941X            Impact factor:   2.752


  9 in total

1.  What type of filling? Best practice in dental restorations.

Authors:  B L Chadwick; P M Dummer; F D Dunstan; A S Gilmour; R J Jones; C J Phillips; J Rees; S Richmond; J Stevens; E T Treasure
Journal:  Qual Health Care       Date:  1999-09

Review 2.  Systematic review of ceramic inlays.

Authors:  M Hayashi; N H F Wilson; C A Yeung; H V Worthington
Journal:  Clin Oral Investig       Date:  2002-12-21       Impact factor: 3.573

3.  Clinical evaluation of ceramic inlays and onlays fabricated with two systems: 12-year follow-up.

Authors:  Maria Jacinta Moraes Coelho Santos; Maria Cristina Freitas; Larissa Marinho Azevedo; Gildo Coelho Santos; Maria Fidela Navarro; Carlos Eduardo Francischone; Rafael Francisco Mondelli
Journal:  Clin Oral Investig       Date:  2015-12-12       Impact factor: 3.573

4.  Effect of selective enamel etching on clinical performance of CAD/CAM partial ceramic crowns luted with a self-adhesive resin cement.

Authors:  Marianne Federlin; Karl-Anton Hiller; Gottfried Schmalz
Journal:  Clin Oral Investig       Date:  2014-01-10       Impact factor: 3.573

5.  Controlled, prospective, randomized, clinical evaluation of partial ceramic crowns inserted with RelyX Unicem with or without selective enamel etching. Results after 2 years.

Authors:  Frederike Schenke; Marianne Federlin; Karl-Anton Hiller; Daniel Moder; Gottfried Schmalz
Journal:  Clin Oral Investig       Date:  2011-03-23       Impact factor: 3.573

6.  Two-year clinical performance of cast gold vs ceramic partial crowns.

Authors:  Marianne Federlin; Tobias Männer; Karl-Anton Hiller; Sebastian Schmidt; Gottfried Schmalz
Journal:  Clin Oral Investig       Date:  2006-04-14       Impact factor: 3.573

7.  Long-term clinical performance and longevity of gold alloy vs ceramic partial crowns.

Authors:  J Wagner; K-A Hiller; G Schmalz
Journal:  Clin Oral Investig       Date:  2003-05-13       Impact factor: 3.573

8.  Three-year clinical performance of cast gold vs ceramic partial crowns.

Authors:  M Federlin; J Wagner; T Männer; K-A Hiller; G Schmalz
Journal:  Clin Oral Investig       Date:  2007-11-01       Impact factor: 3.573

Review 9.  A systematic review of outcome measurements and quality of studies evaluating fixed tooth-supported restorations.

Authors:  Devangkumar Rajnikant Patel; Tim O'Brien; Aviva Petrie; Haralampos Petridis
Journal:  J Prosthodont       Date:  2014-06-19       Impact factor: 2.752

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.